A Phase I Study to Evaluate the Safety and Parmacokineti

Project: Research project

Project Details

Description

A Phase I Study to Evaluate the Safety and Parmacokinetics of Panitumumab in Children with Solid Tumors
StatusFinished
Effective start/end date11/29/0712/30/15

Funding

  • Amgen Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.